Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Rallybio Corp maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -3266.51%, while the net margin is 7554.72%. These profitability ratios, combined with a Return on Equity (ROE) of -21.17%, provide a clear picture of how effectively RLYB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, RLYB competes directly with industry leaders such as BOLD and XCUR. With a market capitalization of $25.45M, it holds a significant position in the sector. When comparing efficiency, RLYB's gross margin of 100.00% stands against BOLD's N/A and XCUR's N/A. Such benchmarking helps identify whether Rallybio Corp is trading at a premium or discount relative to its financial performance.
